Becton, Dickinson and Company (BDX) Competitors

$146.04 -1.47 (-1.00%)

As of 09:31 AM Eastern

BDX vs. COO, HSIC, AMN, CAH, and DVA

Should you buy Becton, Dickinson and Company stock or one of its competitors? MarketBeat compares Becton, Dickinson and Company with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Becton, Dickinson and Company include Cooper Companies (COO), Henry Schein (HSIC), AMN Healthcare Services (AMN), Cardinal Health (CAH), and DaVita (DVA). These companies are all part of the "medical" sector.

How does Becton, Dickinson and Company compare to Cooper Companies?

Becton, Dickinson and Company (NYSE:BDX) and Cooper Companies (NASDAQ:COO) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, media sentiment, valuation, dividends and analyst recommendations.

In the previous week, Becton, Dickinson and Company had 15 more articles in the media than Cooper Companies. MarketBeat recorded 26 mentions for Becton, Dickinson and Company and 11 mentions for Cooper Companies. Cooper Companies' average media sentiment score of 1.08 beat Becton, Dickinson and Company's score of 0.58 indicating that Cooper Companies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Becton, Dickinson and Company	9 Very Positive mention(s)	2 Positive mention(s)	10 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Cooper Companies	6 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Becton, Dickinson and Company has higher revenue and earnings than Cooper Companies. Cooper Companies is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Becton, Dickinson and Company	$21.84B	1.84	$1.68B	$3.95	36.97
Cooper Companies	$4.09B	2.87	$374.90M	$2.02	29.76

Cooper Companies has a net margin of 9.67% compared to Becton, Dickinson and Company's net margin of 5.33%. Becton, Dickinson and Company's return on equity of 15.37% beat Cooper Companies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Becton, Dickinson and Company	5.33%	15.37%	7.11%
Cooper Companies	9.67%	10.34%	6.93%

Becton, Dickinson and Company presently has a consensus price target of $184.86, suggesting a potential upside of 26.58%. Cooper Companies has a consensus price target of $90.79, suggesting a potential upside of 51.04%. Given Cooper Companies' stronger consensus rating and higher possible upside, analysts plainly believe Cooper Companies is more favorable than Becton, Dickinson and Company.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Becton, Dickinson and Company	1 Sell rating(s)	8 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.38
Cooper Companies	1 Sell rating(s)	7 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.53

Becton, Dickinson and Company has a beta of 0.22, suggesting that its stock price is 78% less volatile than the broader market. Comparatively, Cooper Companies has a beta of 0.89, suggesting that its stock price is 11% less volatile than the broader market.

87.0% of Becton, Dickinson and Company shares are held by institutional investors. Comparatively, 24.4% of Cooper Companies shares are held by institutional investors. 0.4% of Becton, Dickinson and Company shares are held by insiders. Comparatively, 2.1% of Cooper Companies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Cooper Companies beats Becton, Dickinson and Company on 9 of the 17 factors compared between the two stocks.

How does Becton, Dickinson and Company compare to Henry Schein?

Becton, Dickinson and Company (NYSE:BDX) and Henry Schein (NASDAQ:HSIC) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings, media sentiment and analyst recommendations.

Becton, Dickinson and Company presently has a consensus target price of $184.86, suggesting a potential upside of 26.58%. Henry Schein has a consensus target price of $86.83, suggesting a potential upside of 23.45%. Given Becton, Dickinson and Company's stronger consensus rating and higher probable upside, research analysts clearly believe Becton, Dickinson and Company is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Becton, Dickinson and Company	1 Sell rating(s)	8 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.38
Henry Schein	1 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.36

87.0% of Becton, Dickinson and Company shares are held by institutional investors. Comparatively, 96.6% of Henry Schein shares are held by institutional investors. 0.4% of Becton, Dickinson and Company shares are held by insiders. Comparatively, 0.9% of Henry Schein shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Becton, Dickinson and Company has a beta of 0.22, suggesting that its share price is 78% less volatile than the broader market. Comparatively, Henry Schein has a beta of 0.82, suggesting that its share price is 18% less volatile than the broader market.

Becton, Dickinson and Company has higher revenue and earnings than Henry Schein. Henry Schein is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Becton, Dickinson and Company	$21.84B	1.84	$1.68B	$3.95	36.97
Henry Schein	$13.38B	0.60	$398M	$3.31	21.25

Becton, Dickinson and Company has a net margin of 5.33% compared to Henry Schein's net margin of 2.95%. Henry Schein's return on equity of 15.44% beat Becton, Dickinson and Company's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Becton, Dickinson and Company	5.33%	15.37%	7.11%
Henry Schein	2.95%	15.44%	5.53%

In the previous week, Becton, Dickinson and Company had 15 more articles in the media than Henry Schein. MarketBeat recorded 26 mentions for Becton, Dickinson and Company and 11 mentions for Henry Schein. Henry Schein's average media sentiment score of 0.91 beat Becton, Dickinson and Company's score of 0.58 indicating that Henry Schein is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Becton, Dickinson and Company	9 Very Positive mention(s)	2 Positive mention(s)	10 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Henry Schein	5 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Becton, Dickinson and Company beats Henry Schein on 11 of the 16 factors compared between the two stocks.

How does Becton, Dickinson and Company compare to AMN Healthcare Services?

AMN Healthcare Services (NYSE:AMN) and Becton, Dickinson and Company (NYSE:BDX) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, profitability, institutional ownership, earnings and risk.

Becton, Dickinson and Company has a net margin of 5.33% compared to AMN Healthcare Services' net margin of -0.95%. AMN Healthcare Services' return on equity of 18.01% beat Becton, Dickinson and Company's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AMN Healthcare Services	-0.95%	18.01%	5.19%
Becton, Dickinson and Company	5.33%	15.37%	7.11%

99.2% of AMN Healthcare Services shares are owned by institutional investors. Comparatively, 87.0% of Becton, Dickinson and Company shares are owned by institutional investors. 1.1% of AMN Healthcare Services shares are owned by insiders. Comparatively, 0.4% of Becton, Dickinson and Company shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

AMN Healthcare Services has a beta of 0.3, meaning that its share price is 70% less volatile than the broader market. Comparatively, Becton, Dickinson and Company has a beta of 0.22, meaning that its share price is 78% less volatile than the broader market.

In the previous week, Becton, Dickinson and Company had 4 more articles in the media than AMN Healthcare Services. MarketBeat recorded 26 mentions for Becton, Dickinson and Company and 22 mentions for AMN Healthcare Services. Becton, Dickinson and Company's average media sentiment score of 0.58 beat AMN Healthcare Services' score of 0.56 indicating that Becton, Dickinson and Company is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AMN Healthcare Services	4 Very Positive mention(s)	4 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Becton, Dickinson and Company	9 Very Positive mention(s)	2 Positive mention(s)	10 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Becton, Dickinson and Company has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AMN Healthcare Services	$2.73B	0.44	-$95.70M	-$0.87	N/A
Becton, Dickinson and Company	$21.84B	1.84	$1.68B	$3.95	36.97

AMN Healthcare Services presently has a consensus target price of $25.29, indicating a potential downside of 18.59%. Becton, Dickinson and Company has a consensus target price of $184.86, indicating a potential upside of 26.58%. Given Becton, Dickinson and Company's higher probable upside, analysts plainly believe Becton, Dickinson and Company is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AMN Healthcare Services	2 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.44
Becton, Dickinson and Company	1 Sell rating(s)	8 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.38

Summary

Becton, Dickinson and Company beats AMN Healthcare Services on 11 of the 17 factors compared between the two stocks.

How does Becton, Dickinson and Company compare to Cardinal Health?

Cardinal Health (NYSE:CAH) and Becton, Dickinson and Company (NYSE:BDX) are both large-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, risk and valuation.

In the previous week, Becton, Dickinson and Company had 16 more articles in the media than Cardinal Health. MarketBeat recorded 26 mentions for Becton, Dickinson and Company and 10 mentions for Cardinal Health. Cardinal Health's average media sentiment score of 0.89 beat Becton, Dickinson and Company's score of 0.58 indicating that Cardinal Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cardinal Health	4 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Becton, Dickinson and Company	9 Very Positive mention(s)	2 Positive mention(s)	10 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

87.2% of Cardinal Health shares are owned by institutional investors. Comparatively, 87.0% of Becton, Dickinson and Company shares are owned by institutional investors. 0.1% of Cardinal Health shares are owned by company insiders. Comparatively, 0.4% of Becton, Dickinson and Company shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Becton, Dickinson and Company has lower revenue, but higher earnings than Cardinal Health. Cardinal Health is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cardinal Health	$222.58B	0.20	$1.56B	$6.54	28.67
Becton, Dickinson and Company	$21.84B	1.84	$1.68B	$3.95	36.97

Cardinal Health has a beta of 0.53, suggesting that its stock price is 47% less volatile than the broader market. Comparatively, Becton, Dickinson and Company has a beta of 0.22, suggesting that its stock price is 78% less volatile than the broader market.

Cardinal Health pays an annual dividend of $2.04 per share and has a dividend yield of 1.1%. Becton, Dickinson and Company pays an annual dividend of $4.20 per share and has a dividend yield of 2.9%. Cardinal Health pays out 31.2% of its earnings in the form of a dividend. Becton, Dickinson and Company pays out 106.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Cardinal Health has raised its dividend for 29 consecutive years and Becton, Dickinson and Company has raised its dividend for 53 consecutive years. Becton, Dickinson and Company is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Cardinal Health presently has a consensus price target of $241.80, indicating a potential upside of 28.97%. Becton, Dickinson and Company has a consensus price target of $184.86, indicating a potential upside of 26.58%. Given Cardinal Health's stronger consensus rating and higher possible upside, analysts clearly believe Cardinal Health is more favorable than Becton, Dickinson and Company.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cardinal Health	0 Sell rating(s)	2 Hold rating(s)	15 Buy rating(s)	1 Strong Buy rating(s)	2.94
Becton, Dickinson and Company	1 Sell rating(s)	8 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.38

Becton, Dickinson and Company has a net margin of 5.33% compared to Cardinal Health's net margin of 0.62%. Becton, Dickinson and Company's return on equity of 15.37% beat Cardinal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cardinal Health	0.62%	-92.61%	4.46%
Becton, Dickinson and Company	5.33%	15.37%	7.11%

Summary

Cardinal Health and Becton, Dickinson and Company tied by winning 10 of the 20 factors compared between the two stocks.

How does Becton, Dickinson and Company compare to DaVita?

DaVita (NYSE:DVA) and Becton, Dickinson and Company (NYSE:BDX) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, risk, media sentiment, profitability and valuation.

DaVita has a net margin of 5.65% compared to Becton, Dickinson and Company's net margin of 5.33%. Becton, Dickinson and Company's return on equity of 15.37% beat DaVita's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DaVita	5.65%	-270.37%	4.87%
Becton, Dickinson and Company	5.33%	15.37%	7.11%

DaVita currently has a consensus price target of $199.17, indicating a potential upside of 1.11%. Becton, Dickinson and Company has a consensus price target of $184.86, indicating a potential upside of 26.58%. Given Becton, Dickinson and Company's higher probable upside, analysts clearly believe Becton, Dickinson and Company is more favorable than DaVita.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DaVita	1 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.38
Becton, Dickinson and Company	1 Sell rating(s)	8 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.38

In the previous week, Becton, Dickinson and Company had 2 more articles in the media than DaVita. MarketBeat recorded 26 mentions for Becton, Dickinson and Company and 24 mentions for DaVita. DaVita's average media sentiment score of 0.71 beat Becton, Dickinson and Company's score of 0.58 indicating that DaVita is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DaVita	7 Very Positive mention(s)	1 Positive mention(s)	12 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Becton, Dickinson and Company	9 Very Positive mention(s)	2 Positive mention(s)	10 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

DaVita has a beta of 0.84, meaning that its stock price is 16% less volatile than the broader market. Comparatively, Becton, Dickinson and Company has a beta of 0.22, meaning that its stock price is 78% less volatile than the broader market.

Becton, Dickinson and Company has higher revenue and earnings than DaVita. DaVita is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DaVita	$13.64B	0.93	$746.80M	$10.78	18.27
Becton, Dickinson and Company	$21.84B	1.84	$1.68B	$3.95	36.97

90.1% of DaVita shares are owned by institutional investors. Comparatively, 87.0% of Becton, Dickinson and Company shares are owned by institutional investors. 1.5% of DaVita shares are owned by company insiders. Comparatively, 0.4% of Becton, Dickinson and Company shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Becton, Dickinson and Company beats DaVita on 9 of the 16 factors compared between the two stocks.

Get Becton, Dickinson and Company News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BDX vs. The Competition

Export

Metric	Becton, Dickinson and Company	MED/DENTAL Industry	Medical Sector	NYSE Exchange
Market Cap	$40.64B	$14.76B	$6.31B	$22.97B
Dividend Yield	2.85%	2.08%	2.79%	4.07%
P/E Ratio	36.73	17.30	21.03	28.29
Price / Sales	1.84	2.12	551.42	24.60
Price / Cash	6.39	12.42	42.94	25.11
Price / Book	1.69	2.95	9.76	4.73
Net Income	$1.68B	$534.24M	$3.55B	$1.07B
7 Day Performance	-4.44%	1.96%	-0.53%	-1.11%
1 Month Performance	-6.22%	-1.51%	1.20%	1.36%
1 Year Performance	-14.70%	-4.66%	41.21%	24.41%

Becton, Dickinson and Company Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BDX Becton, Dickinson and Company	4.8673 of 5 stars	$146.04 -1.0%	$184.86 +26.6%	-17.9%	$40.64B	$21.84B	36.73	72,000	Earnings Report Analyst Forecast
COO Cooper Companies	4.2232 of 5 stars	$58.98 -1.7%	$90.79 +53.9%	-27.3%	$11.51B	$4.15B	29.20	15,000	Positive News
HSIC Henry Schein	4.2633 of 5 stars	$68.99 -2.6%	$86.83 +25.9%	-1.5%	$7.86B	$13.38B	20.84	25,000	Insider Trade
AMN AMN Healthcare Services	1.7495 of 5 stars	$30.43 +5.0%	$23.50 -22.8%	+41.3%	$1.18B	$2.73B	N/A	2,664	Earnings Report Analyst Forecast High Trading Volume
CAH Cardinal Health	4.8823 of 5 stars	$182.63 -0.6%	$241.80 +32.4%	+25.7%	$42.77B	$222.58B	27.93	57,700

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:BDX) was last updated on 5/14/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Becton, Dickinson and Company (BDX) Competitors

BDX vs. COO, HSIC, AMN, CAH, and DVA

How does Becton, Dickinson and Company compare to Cooper Companies?

Summary

How does Becton, Dickinson and Company compare to Henry Schein?

Summary

How does Becton, Dickinson and Company compare to AMN Healthcare Services?

Summary

How does Becton, Dickinson and Company compare to Cardinal Health?

Summary

How does Becton, Dickinson and Company compare to DaVita?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BDX vs. The Competition

Becton, Dickinson and Company Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Becton, Dickinson and Company (BDX) Competitors

BDX vs. COO, HSIC, AMN, CAH, and DVA

How does Becton, Dickinson and Company compare to Cooper Companies?

Does the media refer more to BDX or COO?

Which has higher earnings and valuation, BDX or COO?

Is BDX or COO more profitable?

Do analysts recommend BDX or COO?

Which has more risk and volatility, BDX or COO?

Do institutionals & insiders have more ownership in BDX or COO?

Summary

How does Becton, Dickinson and Company compare to Henry Schein?

Do analysts prefer BDX or HSIC?

Do insiders and institutionals have more ownership in BDX or HSIC?

Which has more volatility & risk, BDX or HSIC?

Which has stronger earnings & valuation, BDX or HSIC?

Is BDX or HSIC more profitable?

Does the media prefer BDX or HSIC?

Summary

How does Becton, Dickinson and Company compare to AMN Healthcare Services?

Is AMN or BDX more profitable?

Do institutionals and insiders believe in AMN or BDX?

Which has more volatility and risk, AMN or BDX?

Does the media favor AMN or BDX?

Which has better valuation and earnings, AMN or BDX?

Do analysts prefer AMN or BDX?

Summary

How does Becton, Dickinson and Company compare to Cardinal Health?

Does the media prefer CAH or BDX?

Do insiders & institutionals have more ownership in CAH or BDX?

Which has better valuation & earnings, CAH or BDX?

Which has more volatility & risk, CAH or BDX?

Is CAH or BDX a better dividend stock?

Do analysts rate CAH or BDX?

Is CAH or BDX more profitable?

Summary

How does Becton, Dickinson and Company compare to DaVita?

Is DVA or BDX more profitable?

Do analysts prefer DVA or BDX?

Does the media prefer DVA or BDX?

Which has more volatility & risk, DVA or BDX?

Which has stronger valuation & earnings, DVA or BDX?

Do insiders and institutionals have more ownership in DVA or BDX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BDX vs. The Competition

Becton, Dickinson and Company Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools